Showing results (891-900 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|December 1, 2007
Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IXKatherine A Lyseng-Williamson, Greg L PloskerPharmacoeconomics|December 1, 2007
Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular eventsGreg L Plosker, Katherine A Lyseng-WilliamsonPharmacoeconomics|March 8, 2006
Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medicationsLawrence D Goldberg, John WaltPharmacoeconomics|January 4, 2026
Spectrum of Models for Assessing the Cost Effectiveness of Total Knee Replacement Implants: A Comparison of Discrete-Time Cohort Markov and Continuous-Time Individual-Level Multistate ModelsYixin Xu, Elsa M R Marques, Nicky J Welton, et al.Pharmacoeconomics|February 8, 2006
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular diseaseMark Lamotte, Lieven Annemans, Thomas Evers, et al.Pharmacoeconomics|February 8, 2006
The long-term cost effectiveness of treatments for benign prostatic hyperplasiaRachael L DiSantostefano, Andrea K Biddle, John P LavellePharmacoeconomics|February 8, 2006
Evaluation of non-medical costs associated with visual impairment in four European countries: France, Italy, Germany and the UKAntoine Lafuma, Antoine Brézin, Stefania Lopatriello, et al.Pharmacoeconomics|February 1, 2006
Incorporating carer effects into economic evaluationSimon Dixon, Mel Walker, Sam SalekPharmacoeconomics|May 21, 2008
Economic burden of heart failure in the elderlyLawrence Liao, Larry A Allen, David J WhellanPharmacoeconomics|April 24, 2008
A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care unitsAna M C Sogayar, Flavia R Machado, Alvaro Rea-Neto, et al.Pageof 336